Cullinan Oncology Valuation
| CGEM Stock | USD 23.46 0.52 2.17% |
At this time, the firm appears to be overvalued. Cullinan Oncology LLC shows a prevailing Real Value of $22.48 per share. The current price of the firm is $23.46. Our model approximates the value of Cullinan Oncology LLC from analyzing the firm fundamentals such as Shares Owned By Insiders of 4.70 %, current valuation of 952.23 M, and Return On Equity of -0.29 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Cullinan Oncology's valuation include:
Price Book 2.785 | Enterprise Value 952.2 M | Enterprise Value Ebitda (4.20) | Price Sales 26.8794 | Forward PE 6.3012 |
Overvalued
Today
Please note that Cullinan Oncology's price fluctuation is somewhat reliable at this time. Calculation of the real value of Cullinan Oncology LLC is based on 3 months time horizon. Increasing Cullinan Oncology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cullinan Oncology LLC is useful when determining the fair value of the Cullinan stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cullinan Oncology. Since Cullinan Oncology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cullinan Stock. However, Cullinan Oncology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.46 | Real 22.48 | Target 24.6 | Hype 24.96 | Naive 18.7 |
The real value of Cullinan Stock, also known as its intrinsic value, is the underlying worth of Cullinan Oncology LLC Company, which is reflected in its stock price. It is based on Cullinan Oncology's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Cullinan Oncology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cullinan Oncology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cullinan Oncology LLC helps investors to forecast how Cullinan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cullinan Oncology more accurately as focusing exclusively on Cullinan Oncology's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cullinan Oncology's intrinsic value based on its ongoing forecasts of Cullinan Oncology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cullinan Oncology's closest peers. When choosing an evaluation method for Cullinan Oncology LLC, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Cullinan Oncology Investments |
|
Cullinan Valuation Trend
Knowing Cullinan Oncology's actual value is paramount for traders to make sound investment determinations. Cullinan Oncology's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Cullinan Oncology's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Cullinan Oncology's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Cullinan Market Cap
Cullinan Oncology LLC is rated fifth in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 18.4 Billion. Cullinan Oncology holds roughly 1.38 Billion in market capitalization claiming about 8% of equities under Health Care industry.Cullinan Oncology Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Cullinan Oncology's current stock value. Our valuation model uses many indicators to compare Cullinan Oncology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cullinan Oncology competition to find correlations between indicators driving Cullinan Oncology's intrinsic value. More Info.Cullinan Oncology LLC is rated fifth in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 0.53 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Cullinan Oncology LLC is roughly 1.88 . As of the 21st of May 2024, Price To Book Ratio is likely to grow to 0.98. Comparative valuation analysis is a catch-all model that can be used if you cannot value Cullinan Oncology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cullinan Oncology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cullinan Oncology's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cullinan Oncology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cullinan Oncology and how it compares across the competition.
About Cullinan Oncology Valuation
The stock valuation mechanism determines the current worth of Cullinan Oncology LLC on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Cullinan Oncology LLC. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cullinan Oncology LLC based exclusively on its fundamental and basic technical indicators. By analyzing Cullinan Oncology's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cullinan Oncology's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cullinan Oncology. We calculate exposure to Cullinan Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cullinan Oncology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -310 K | -294.5 K | |
| Pretax Profit Margin | (3.21) | (3.37) | |
| Operating Profit Margin | (3.23) | (3.39) | |
| Net Loss | (3.09) | (3.24) | |
| Gross Profit Margin | 0.90 | 0.80 |
8 Steps to conduct Cullinan Oncology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cullinan Oncology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cullinan Oncology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cullinan Oncology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cullinan Oncology's revenue streams: Identify Cullinan Oncology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cullinan Oncology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cullinan Oncology's growth potential: Evaluate Cullinan Oncology's management, business model, and growth potential.
- Determine Cullinan Oncology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cullinan Oncology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cullinan Oncology Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Cullinan Oncology does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 41.5 M | |
| Forward Price Earnings | 6.3012 |
Cullinan Oncology Current Valuation Indicators
Valuation refers to the process of determining the present value of Cullinan Oncology LLC and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cullinan we look at many different elements of the entity such as Cullinan's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Cullinan Oncology's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cullinan Oncology's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cullinan Oncology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cullinan Oncology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cullinan Oncology's worth.When determining whether Cullinan Oncology LLC is a strong investment it is important to analyze Cullinan Oncology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cullinan Oncology's future performance. For an informed investment choice regarding Cullinan Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cullinan Oncology LLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Cullinan Oncology LLC information on this page should be used as a complementary analysis to other Cullinan Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Cullinan Stock analysis
When running Cullinan Oncology's price analysis, check to measure Cullinan Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cullinan Oncology is operating at the current time. Most of Cullinan Oncology's value examination focuses on studying past and present price action to predict the probability of Cullinan Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cullinan Oncology's price. Additionally, you may evaluate how the addition of Cullinan Oncology to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Cullinan Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cullinan Oncology. If investors know Cullinan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cullinan Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.13) | Return On Assets (0.22) | Return On Equity (0.29) |
The market value of Cullinan Oncology LLC is measured differently than its book value, which is the value of Cullinan that is recorded on the company's balance sheet. Investors also form their own opinion of Cullinan Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cullinan Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cullinan Oncology's market value can be influenced by many factors that don't directly affect Cullinan Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cullinan Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cullinan Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cullinan Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.